Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 3, 2015
Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastomaGuendalina Zuccari, Andrea Milelli, Fabio Pastorino, et al.
Cancers|February 11, 2023
Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric OncologyFabio Pastorino, Mario Capasso, Chiara Brignole, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 24, 2020
Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical ModelsDaniela Di Paolo, Fabio Pastorino, Chiara Brignole, et al.
Ebiomedicine|October 9, 2022
Nucleolin expression has prognostic value in neuroblastoma patientsDavide Cangelosi, Chiara Brignole, Veronica Bensa, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 30, 2010
Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastomaMonica Loi, Serena Marchiò, Pamela Becherini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicinFabio Pastorino, Daniela Di Paolo, Federica Piccardi, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 9, 2018
Enhancement of Tumor Homing by Chemotherapy-Loaded NanoparticlesMirco Ponzoni, Flavio Curnis, Chiara Brignole, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 30, 2013
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settingsMonica Loi, Daniela Di Paolo, Marco Soster, et al.
Pageof 7